- ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers.
- Providing more formalized structure around the Strategy’s portfolio construction approach should enable us to better identify and prioritize investment opportunities across a spectrum of growth.
- We anticipate increasing exposure to disruptive companies early on in their lifecycle with long runways for growth ahead, while balancing these high-growth stocks with allocations to durable compounders, cyclical growers and improving growth stories.
- We also plan to broaden out the portfolio’s industryweightings, but expect to maintain an overweight to areasof rapid innovation, such as health care. FDA approval oflongtime holding Biogen’s Alzheimer’s treatmentdemonstrates the potential of innovation in the healthcare sector to generate long-term growth and attractivereturns for shareholders.
For further details see:
ClearBridge Aggressive Growth Strategy Portfolio Manager Commentary Q2 2021